Berlin - Delayed Quote EUR
Syndax Pharmaceuticals Inc (1T3.BE)
12.00
-0.50
(-4.00%)
At close: May 2 at 9:52:09 PM GMT+2
Loading Chart for 1T3.BE
- Previous Close
12.50 - Open
12.10 - Bid 12.00 x --
- Ask 12.30 x --
- Day's Range
12.00 - 12.30 - 52 Week Range
8.90 - 23.00 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 1T3.BE
View MorePerformance Overview: 1T3.BE
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1T3.BE
0.83%
S&P 500 (^GSPC)
3.31%
1-Year Return
1T3.BE
41.18%
S&P 500 (^GSPC)
12.29%
3-Year Return
1T3.BE
26.83%
S&P 500 (^GSPC)
36.85%
5-Year Return
1T3.BE
29.41%
S&P 500 (^GSPC)
100.89%
Compare To: 1T3.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
440.30
-1.21%
Mkt Cap EUR 113.253B
Industry Biotechnology
Statistics: 1T3.BE
View MoreValuation Measures
As of 5/2/2025
Market Cap
1.04B
Enterprise Value
833.81M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
49.13
Price/Book (mrq)
4.06
Enterprise Value/Revenue
39.87
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--